Latest News and Press Releases

Reports First Quarter 2023 Net Sales of $290.5 MillionAchieves Record Quarterly Net IncomeRecord Quarterly Adjusted EBITDA Exceeds Company's First Quarter 2023 GuidanceReiterates 2023 Annual Outlook ...

EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial...

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company GuidanceUpdates Adjusted EBITDA MethodologyReports Record Annual Cash from Operations of $48.0 MillionCompletes Complementary, Margin...

EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results...

Third Quarter 2022 Net Sales of Approximately $210 Million at the High-End of Guidance Adjusted EBITDA Exceeds Company's Third Quarter Guidance Reports Record Quarterly Cash from Operations of $64.5...

EAGLE, Idaho, Oct. 19, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results...

EAGLE, Idaho, Sept. 06, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that as part of the Company's...

Second Quarter 2022 Net Income Increased 16.0% to $4.7 MillionReports Adjusted EBITDA of Approximately $28 MillionProvides Third Quarter 2022 Guidance and Updates 2022 Annual Outlook ...

EAGLE, Idaho, July 19, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results...

EAGLE, Idaho, May 23, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that members of the management...